Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
429.9 USD | +1.69% | +6.81% | +5.66% |
11:53am | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
10/05 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.66% | 11TCr | |
+11.23% | 11TCr | |
-2.79% | 2.19TCr | |
-12.15% | 2.23TCr | |
-5.48% | 1.86TCr | |
-36.52% | 1.81TCr | |
-10.09% | 1.7TCr | |
+3.33% | 1.37TCr | |
+36.58% | 1.24TCr | |
+288.77% | 797.79Cr |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated Presents at Credit Suisse 28th Annual Healthcare Conference, Nov-12-2019 11